• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    6/14/23 1:12:22 PM ET
    $AAMC
    $AFRM
    $AGL
    $AHI
    Real Estate
    Finance
    Finance: Consumer Services
    Finance
    Get the next $AAMC alert in real time by email

    Gainers

    • WeTrade Group, Inc. (NASDAQ:WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial intelligence.
    • Cyxtera Technologies, Inc. (NASDAQ:CYXT) shares climbed 71.5% to $0.0717 after dropping 12% on Tuesday.
    • Blue Water Biotech, Inc. (NASDAQ:BWV) gained 67% to $1.32 after the company acquired six FDA-approved drugs across various treatment areas
    • WiSA Technologies, Inc. (NASDAQ:WISA) shares surged 51.7% to $1.9575. WiSA Technologies started taking pre-orders for WiSA E multichannel audio development kits.
    • NextDecade Corporation (NASDAQ:NEXT) gained 35% to $6.93 after the company announced it has entered into framework agreements with Global Infrastructure Partners and TotalEnergies to support the development of the Rio Grande LNG project.
    • Ideanomics, Inc. (NASDAQ:IDEX) rose 27.6% to $0.1177.
    • Inventiva S.A. (NASDAQ:IVA) shares climbed 22.3% to $4.49 after the company announced its Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD achieved its primary efficacy endpoint.
    • Greenidge Generation Holdings Inc. (NASDAQ:GREE) gained 21.3% to $1.93.
    • Coherent Corp. (NYSE:COHR) surged 17% to $50.13.
    • Leju Holdings Limited (NYSE:LEJU) rose 16.9% to $2.9699.
    • IPG Photonics Corporation (NASDAQ:IPGP) climbed 16.1% to $135.92. Raymond James upgraded IPG Photonics from Market Perform to Outperform and announced a $170 price target.
    • Akoya Biosciences, Inc. (NASDAQ:AKYA) gained 15.5% to $7.57.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) surged 13.6% to $1.3410.
    • Microvast Holdings, Inc. (NASDAQ:MVST) jumped 12.7% to $1.7698.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 11.7% to $0.0696. T2 Biosystems recently reported a clinical collaboration with Vanderbilt University Medical Center to implement and evaluate the T2Bacteria panel for clinical use.
    • Nikola Corporation (NASDAQ:NKLA) rose 9.4% to $1.00 after jumping over 19% on Tuesday.
    • Matterport, Inc. (NASDAQ:MTTR) gained 8.8% to $3.1898. Matterport announced Genesis, a generative AI initiative to transform how buildings are designed, built, and managed.
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) climbed 8.7% to $0.8586. Accelerate Diagnostics recently posted downbeat quarterly results.
    • NightHawk Biosciences, Inc. (NYSE:NHWK) shares gained 7.8% to $0.67.

    Losers

    • Tenon Medical, Inc. (NASDAQ:TNON) shares dipped 56.5% to $0.2693 after it priced its public offering of $5.6M at $0.56 per unit.
    • Advanced Health Intelligence Ltd. (NASDAQ:AHI) fell 39.3% to $0.9102 after dropping over 37% on Tuesday. Advanced Health Intelligence said it will undertake AUD$5 million private placement.
    • Cineverse Corp. (NASDAQ:CNVS) shares fell 37.1% to $2.24 after the company reported pricing of $8 million public offering.
    • IperionX Limited (NASDAQ:IPX) dropped 29.2% to $9.35. IperionX shares climbed over 100% on Tuesday after the company announced it will produce titanium components for the Ford Motor Company.
    • IO Biotech, Inc. (NASDAQ:IOBT) fell 23.8% to $1.63 after the company increased the enrolled patients in Phase 3 trial to 380, potentially accelerating the time to reach the primary end point of progression free survival.
    • FLJ Group Limited (NASDAQ:FLJ) dropped 22.7% to $0.3095.
    • MicroVision, Inc. (NASDAQ:MVIS) fell 22.4% to $4.9401 after the company filed for a mixed shelf offering.
    • Eastside Distilling, Inc. (NASDAQ:EAST) fell 22.1% to $4.8505 after the company disclosed business and financial updates.
    • MIND Technology, Inc. (NASDAQ:MIND) declined 20.6% to $0.6208 following wider-than-expected quarterly loss.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) fell 18.1% to $0.42.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) dropped 16.6% to $0.6407. SMX achieved 100% year-to-date growth in commercialization driven by client adoption & transformation across industries.
    • agilon health, inc. (NYSE:AGL) dropped 14.2% to $18.08.
    • Allogene Therapeutics, Inc. (NASDAQ:ALLO) dropped 13.3% to $4.94. Allogene Therapeutics reported the departure of CFO Eric T. Schmidt.
    • Mullen Automotive, Inc. (NASDAQ:MULN) dipped 13.2% to $0.279.
    • Humana Inc. (NYSE:HUM) fell 13.1% to $445.64. Shares of several health insurers traded lower following comments from UnitedHealth Group CEO highlighting an increase in elevated volumes of non-urgent surgeries, which has increased fears of higher costs for insurers.
    • agilon health, inc. (NYSE:AGL) dropped 12.2% to $18.45. Evercore ISI Group initiated coverage on Agilon Health with an In-Line rating and announced a price target of $22.5.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) fell 12% to $0.3346 after jumping over 22% on Tuesday.
    • Altisource Asset Management Corporation (NASDAQ:AAMC) declined 11.8% to $54.35. Altisource Asset Management reported favorable ruling from New York Appellate Court.
    • Logitech International S.A. (NASDAQ:LOGI) shares dropped 11.8% to $56.35. Logitech said President and CEO Bracken Darrell will be departing to pursue another opportunity.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) fell 11.5% to $5.62.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) fell 9.6% to $16.93 after BTIG initiated coverage on the stock with a Sell rating and announced a $10 price target.
    • Centene Corporation (NYSE:CNC) dropped 7.7% to $64.11. Shares of several health insurers traded lower following comments from UnitedHealth Group CEO highlighting an increase in elevated volumes of non-urgent surgeries, which has increased fears of higher costs for insurers.
    • UnitedHealth Group Incorporated (NYSE:UNH) shares declined 7.1% to $456.70 after the company's CEO highlighted an increase in elevated volumes of non-urgent surgeries, which has increased fears of higher costs for insurers.
    • Icahn Enterprises L.P. (NASDAQ:IEP) fell 7% to $28.40.
    • Cinemark Holdings, Inc. (NYSE:CNK) dropped 6.6% to $17.18. B. Riley Securities downgraded Cinemark from Buy to Neutral and lowered the price target from $21 to $20.
    • Kura Oncology, Inc. (NASDAQ:KURA) shares fell 5.3% to $12.05 after the company reported commencement of $100 million public offering of common stock and pre-funded warrants.
    • RadNet, Inc. (NASDAQ:RDNT) shares fell 5.2% to $31.21. Radnet priced an underwritten offering of 7.575 million shares at $29.75 per share, with gross proceeds of approximately $225 million.

     

    Now Read This: Kroger Likely To Report Flat Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $AFRM
    $AGL
    $AHI

    CompanyDatePrice TargetRatingAnalyst
    Affirm Holdings Inc.
    $AFRM
    4/22/2026$75.00Outperform
    BMO Capital Markets
    UnitedHealth Group Incorporated
    $UNH
    4/22/2026$400.00Hold → Buy
    Argus
    Allogene Therapeutics Inc.
    $ALLO
    4/16/2026Underweight → Neutral
    Analyst
    Kura Oncology Inc.
    $KURA
    4/14/2026$23.00Buy
    Lake Street
    Allogene Therapeutics Inc.
    $ALLO
    4/10/2026$6.00Buy
    Jefferies
    UnitedHealth Group Incorporated
    $UNH
    4/7/2026$300.00Reduce → Hold
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    IperionX Limited
    $IPX
    3/27/2026$40.00Buy
    BTIG Research
    More analyst ratings

    $AAMC
    $AFRM
    $AGL
    $AHI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

    TOKYO and SAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE: 4151, "Kyowa Kirin") and Kura Oncology, Inc. (NASDAQ:KURA, "Kura")) today announced the first patient has been dosed in a Japanese Phase 2 registrational clinical trial (jRCT2031250550) studying ziftomenib, an oral menin inhibitor, for the treatment of relapsed or refractory (R/R) NPM1-mutated (NPM1-m) acute myeloid leukemia (AML). NPM1-m AML accounts for approximately 30% of AML patients. The initiation of this trial represents a significant step forward toward establishing a potential new treatment option for patients in Japan. Following completion of this clinical trial, Kyowa Kirin plans to file for reg

    4/24/26 8:00:00 AM ET
    $KURA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements

    Company expects more than 70% of prior authorization volume to be part of new standardized submission process by year‑end Latest in continuing series of company actions to simplify and ease administrative requirements UnitedHealthcare today announced more than half of its prior authorization volume will be included in an industrywide effort to standardize submission requirements for electronic prior authorization, and that number will advance to more than 70% by the end of 2026. This step is the next phase of the company's ongoing efforts to modernize and simplify prior authorization for care providers and help patients more easily and quickly access safe, high‑quality, evidence‑based c

    4/24/26 7:08:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    Centene Foundation Reports $34.9 Million Invested in Community Health, Education and Social Services in 2025

    Year-end Report Highlights Local Partnerships, Measurable Impact and a Growing National StrategyST. LOUIS, April 23, 2026 /PRNewswire/ -- The Centene Foundation, the philanthropic arm of  Centene Corporation (NYSE:CNC), today released its 2025 Year-end Report, detailing $34.9 million in philanthropic investments made across 209 nonprofit organizations in 29 states and the District of Columbia, reinforcing the Foundation's commitment to improving community health through locally driven solutions and strategic national partnerships. In 2025, the Foundation directed funding to init

    4/23/26 9:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $AAMC
    $AFRM
    $AGL
    $AHI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Markets Officer Shaker Benjamin bought $301,050 worth of shares (500,000 units at $0.60), increasing direct ownership by 58% to 1,367,674 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    3/3/26 5:28:28 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $AFRM
    $AGL
    $AHI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF LEGAL OFFICER Harnett Samantha was granted 5,757 units of Registered Shares, increasing direct ownership by 35% to 22,022 units (SEC Form 4)

    4 - LOGITECH INTERNATIONAL S.A. (0001032975) (Issuer)

    4/23/26 6:36:56 PM ET
    $LOGI
    Computer peripheral equipment
    Technology

    Chief Financial Officer Anversa Matteo was granted 8,956 units of Registered Shares, increasing direct ownership by 118% to 16,558 units (SEC Form 4)

    4 - LOGITECH INTERNATIONAL S.A. (0001032975) (Issuer)

    4/23/26 6:35:02 PM ET
    $LOGI
    Computer peripheral equipment
    Technology

    SVP, Finance Yoshiyama Annie sold $22,144 worth of shares (9,586 units at $2.31), decreasing direct ownership by 7% to 124,517 units (SEC Form 4) to satisfy withholding tax

    4 - Allogene Therapeutics, Inc. (0001737287) (Issuer)

    4/23/26 4:16:11 PM ET
    $ALLO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAMC
    $AFRM
    $AGL
    $AHI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Affirm with a new price target

    BMO Capital Markets initiated coverage of Affirm with a rating of Outperform and set a new price target of $75.00

    4/22/26 7:55:46 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    UnitedHealth upgraded by Argus with a new price target

    Argus upgraded UnitedHealth from Hold to Buy and set a new price target of $400.00

    4/22/26 7:35:11 AM ET
    $UNH
    Medical Specialities
    Health Care

    Allogene upgraded by Analyst

    Analyst upgraded Allogene from Underweight to Neutral

    4/16/26 7:57:56 AM ET
    $ALLO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAMC
    $AFRM
    $AGL
    $AHI
    SEC Filings

    View All

    SEC Form DEF 14A filed by NextDecade Corporation

    DEF 14A - NextDecade Corp (0001612720) (Filer)

    4/23/26 5:17:57 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    SEC Form DEFA14A filed by agilon health inc.

    DEFA14A - agilon health, inc. (0001831097) (Filer)

    4/23/26 4:42:13 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEF 14A filed by agilon health inc.

    DEF 14A - agilon health, inc. (0001831097) (Filer)

    4/22/26 4:49:23 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AAMC
    $AFRM
    $AGL
    $AHI
    Financials

    Live finance-specific insights

    View All

    IPG Photonics to Announce First Quarter 2026 Financial Results on May 5

    MARLBOROUGH, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ:IPGP) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived in the investor relations section of the Company's website at investor.ipgphotonics.com. About IPG Photonics Corporation IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processi

    4/21/26 8:00:00 AM ET
    $IPGP
    Semiconductors
    Technology

    UnitedHealth Group Reports First Quarter 2026 Results

    First Quarter 2026 Revenues of $111.7 Billion Grew 2% Year-over-Year Earnings of $6.90 Per Share and Adjusted Earnings of $7.23 Per Share Full Year 2026 Earnings Outlook Raised to Greater Than $17.35 Per Share; Adjusted Earnings of Greater Than $18.25 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-first-quarter-2026-results.pdf UnitedHealth Group (NYSE:UNH) today reported first quarter 2026 results, with performance supported by actions taken over the last several quarters. This press release features multimedia. View the full rel

    4/21/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    Cinemark to Host First Quarter 2026 Earnings Conference Call

    Cinemark Holdings, Inc. ("Cinemark") (NYSE:CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that it will report its first quarter 2026 operating results and associated executive commentary pre-market and host a webcast to discuss the results on: Friday, May 1, 2026 8:30 a.m. Eastern Time Interested parties can listen to the call via live webcast. Please access 5-10 minutes before the call: https://event.choruscall.com/mediaframe/webcast.html?webcastid=RZXqr90L A replay of the call will be available at https://ir.cinemark.com following the call and archived for a limited time. To automatically receive Cinemark financial news

    4/17/26 8:30:00 AM ET
    $CNK
    Movies/Entertainment
    Consumer Discretionary

    $AAMC
    $AFRM
    $AGL
    $AHI
    Leadership Updates

    Live Leadership Updates

    View All

    Coherent Corp. Announces Timing of FY2026 Third Quarter Earnings Release

    SAXONBURG, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR) ("Coherent," "We," or the "Company"), a global leader in photonics, announced today that it will release its financial results for the quarter ended March 31, 2026, on Wednesday, May 6, after the New York Stock Exchange closes. The release will be followed by a live audio webcast at 4:30 p.m. ET to discuss the results. The Company invites investors to join the live audio webcast at coherent.com/company/ investor-relations/financial-webcasts. The webcast will be recorded and a replay will be available within 24 hours after the live audio webcast on the company's website. About Coherent Coherent is the global ph

    4/22/26 7:00:00 AM ET
    $COHR
    Electronic Components
    Technology

    Premium In-Lobby Media Network Coming to 285 Movie Theatres Nationwide in a New Initiative from National CineMedia and Creative Realities

    National CineMedia (NASDAQ:NCMI) ("NCM"), the leading cinema advertising platform in the U.S. and a leading provider of digital signage, experiential solutions, and media network management, and Creative Realities, Inc. (NASDAQ:CREX) ("CRI"), a leading provider of digital media and AdTech solutions, today announced a new partnership to significantly expand and modernize AMC Theatres' (NYSE:AMC) in-lobby media footprint across 285 locations nationwide. This new initiative will turn the lobby at the participating theaters into a network of digital displays, including multiple 75-inch screens per location, that will deliver high-impact video, brand storytelling, and interactive experiences.

    4/13/26 8:00:00 AM ET
    $AMC
    $CNK
    $CREX
    Movies/Entertainment
    Consumer Discretionary
    EDP Services
    Technology

    Centene Announces New Executive Leadership Structure

    Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty  ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. "We are pl

    4/6/26 7:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $AAMC
    $AFRM
    $AGL
    $AHI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Kura Oncology Inc.

    SC 13G - Kura Oncology, Inc. (0001422143) (Subject)

    12/5/24 6:55:37 PM ET
    $KURA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Accelerate Diagnostics Inc.

    SC 13D/A - Accelerate Diagnostics, Inc (0000727207) (Subject)

    12/5/24 5:13:13 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13D/A filed by Microvast Holdings Inc.

    SC 13D/A - Microvast Holdings, Inc. (0001760689) (Subject)

    11/21/24 9:41:30 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    $AAMC
    $AFRM
    $AGL
    $AHI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care